135 related articles for article (PubMed ID: 19666396)
1. Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients.
Bölke E; Orth K; Gerber PA; Lammering G; Mota R; Peiper M; Matuschek C; Budach W; Rusnak E; Shaikh S; Dogan B; Prisack HB; Bojar H
Eur J Med Res; 2009 Aug; 14(8):359-63. PubMed ID: 19666396
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of circulating tumour cells in breast cancer patients.
Bölke E; Orth K; Gerber PA; Lammering G; Mota R; Peiper M; Matuschek C; Budach W; Rusnak E; Shaikh S; Dogan B; Prisack HB; Bojar H
Eur J Med Res; 2009 Sep; 14(10):426-32. PubMed ID: 19748849
[TBL] [Abstract][Full Text] [Related]
3. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR.
Raynor MP; Stephenson SA; Pittman KB; Walsh DC; Henderson MA; Dobrovic A
J Hematol Oncol; 2009 Jun; 2():24. PubMed ID: 19500345
[TBL] [Abstract][Full Text] [Related]
4. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract][Full Text] [Related]
7. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
[TBL] [Abstract][Full Text] [Related]
8. Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
Gargano G; Agnese V; Calò V; Corsale S; Augello C; Bruno L; La Paglia L; Gullo A; Ottini L; Russo A; Fulfaro F; Rinaldi G; Crosta A; Cicero G; Majorana O; Palmeri L; Cipolla C; Agrusa A; Gulotta G; Morello V; Di Fede G; Adamo V; Colucci G; Tomasino RM; Valerio MR; Bazan V; Russo A;
Ann Oncol; 2006 Jun; 17 Suppl 7():vii41-5. PubMed ID: 16760290
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
[TBL] [Abstract][Full Text] [Related]
10. Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.
Kuniyoshi RK; Gehrke Fde S; Alves BC; Vilas-Bôas V; Coló AE; Sousa N; Nunes J; Fonseca FL; Del Giglio A
Tumour Biol; 2015 Sep; 36(10):8075-83. PubMed ID: 25976504
[TBL] [Abstract][Full Text] [Related]
11. Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review).
Andergassen U; Kölbl AC; Mahner S; Jeschke U
Oncol Rep; 2016 Apr; 35(4):1905-15. PubMed ID: 26848098
[TBL] [Abstract][Full Text] [Related]
12. New Marker Genes for Real-Time PCR-based Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients.
Kölbl AC; Bräuer D; Hutter S; Rack B; Friese K; Jeschke U; Andergassen U
Anticancer Res; 2016 Jun; 36(6):3211-6. PubMed ID: 27272851
[TBL] [Abstract][Full Text] [Related]
13. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
14. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
15. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
Bossolasco P; Ricci C; Farina G; Soligo D; Pedretti D; Scanni A; Deliliers GL
Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.
Markou A; Strati A; Malamos N; Georgoulias V; Lianidou ES
Clin Chem; 2011 Mar; 57(3):421-30. PubMed ID: 21245367
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
18. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients.
Cerveira N; Torres L; Rocha P; Bizarro S; Pereira D; Abreu J; Henrique R; Teixeira MR; Castedo S
Int J Cancer; 2004 Feb; 108(4):592-5. PubMed ID: 14696125
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years.
Pierga JY; Bidard FC; Denis MG; de Cremoux P
Mol Oncol; 2007 Dec; 1(3):267-8. PubMed ID: 19383302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
